# Editorial: Paradigm shifts and innovations in cellular neuroscience

**Authors:** Enrico Cherubini, Arianna Maffei, Egidio D'Angelo, Dirk M. Hermann, Marie-Ève Tremblay, Christian Hansel

PMC · DOI: 10.3389/fncel.2025.1644329 · 2025-07-14

## Full-text entities

- **Genes:** GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, VIM (vimentin) [NCBI Gene 7431], GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B) [NCBI Gene 2904] {aka DEE27, EIEE27, GluN2B, MRD6, NMDAR2B, NR2B}, SYNPO (synaptopodin) [NCBI Gene 11346] {aka SYNPO1}, CCK (cholecystokinin) [NCBI Gene 885], GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A) [NCBI Gene 2903] {aka EPND, FESD, GluN2A, LKS, NMDAR2A, NR2A}
- **Diseases:** Tuberous Sclerosis (MESH:D014402), obesity (MESH:D009765), neuroblastoma (MESH:D009447), epilepsy (MESH:D004827), cortical malformations (MESH:D054220), ET (MESH:D016751), neurodegenerative diseases (MESH:D019636), Cortical Dysplasia Type II (MESH:C537067), malformations (MESH:C564254), myoclonic movements (MESH:D004831)
- **Chemicals:** glucose (MESH:D005947), calcium (MESH:D002118), DREADDS (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Enterovirus C (no rank) [taxon 138950], Mus musculus (house mouse, species) [taxon 10090]

---
Source: https://tomesphere.com/paper/PMC12301337